Quantitative analysis of the olfactory pathway for drug delivery to the brain.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Brain Research

• Publication date

  1995-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-8993(95)00637-6PMID 8548316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat

  2004cited by this paper
• Uptake of exogenous proteins in mouse olfactory cells

  2004cited by this paper
• Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection

  1993cited by this paper
• Localization of neurotrophin receptors in olfactory epithelium and bulb.

  1993cited by this paper
• Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study.

  1993cited by this paper
• Olfactory primary neurons as a route of entry for toxic agents into the CNS.

  1991cited by this paper
• Peptide drug delivery to the brain

  1991cited by this paper
• BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

  1991cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery.

  1990cited by this paper
• Pathological changes in olfactory neurons in patients with Alzheimer's disease

  1989cited by this paper
• Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons.

  1989cited by this paper
• Intranasal drug delivery for systemic medications.

  1987cited by this paper
• The spatial organization of olfactory nerve projections.

  1987cited by this paper
• Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

  1986cited by this paper
• Endocytic and exocytic pathways of the neuronal secretory process and trans synaptic transfer of wheat germ agglutinin‐horseradish peroxidase in vivo

  1985cited by this paper
• Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium.

  1985cited by this paper
• Labelling of olfactory bulb glomeruli following horseradish peroxidase lavage of the nasal cavity.

  1985cited by this paper
• Immunoblot analysis of horseradish peroxidase conjugates of wheat germ agglutinin before and after retrograde transport in the rat peripheral nervous system

  1985cited by this paper
• Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

  1985cited by this paper
• Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying.

  1982cited by this paper
• Conjugates of horseradish peroxidase (HRP) with cholera toxin and wheat germ agglutinin are superior to free HRP as orthogradely transported markers.

  1981cited by this paper
• Fixation variables in horseradish peroxidase neurohistochemistry. I. The effect of fixation time and perfusion procedures upon enzyme activity.

  1978cited by this paper
• FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE

  1967cited by this paper

• Revisited case for intranasal neuropeptide Y based therapeutics: From preclinical to clinical

  2026cites this paper
• Intranasal Delivery of Natural Compounds: A Promising approach for Parkinson’s Disease therapy

  2026cites this paper
• Multifunctional approaches of cubosome-integrated thermoresponsive gels for intranasal brain targeting: Innovations, therapeutic potential, and challenges

  2026cites this paper
• Focused ultrasound-enhanced nose-to-brain delivery of a therapeutic antibody in a large-animal model

  2026cites this paper
• [Development of Drug Delivery Systems Based on New Concepts].

  2025cites this paper
• Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease

  2025cites this paper
• Intranasal Galanin (1–15) modulates alcohol self-administration and depressive-like behavior in rats and shows a favorable safety profile

  2025cites this paper
• Intranasal delivery of drug-loaded polymeric nanomicelles for brain targeting: a comprehensive review

  2025cites this paper
• The olfactory epithelium as a gateway for bloodborne nanoparticles to the central nervous system.

  2025cites this paper
• Challenges and strategies for nose-to-brain delivery in treating neurological disorders

  2025cites this paper
• Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice

  2025cites this paper
• Grueneberg Ganglion: An Unexplored Site for Intranasal Drug Delivery in Alzheimer's Disease.

  2025cites this paper
• Advances in cell-penetrating peptide-based nose-to-brain drug delivery systems.

  2025cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Nose-to-brain drug delivery: from bench to bedside

  2025cites this paper
• Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation.

  2024cites this paper
• Biosocial effects of oxytocin in vertebrates: From hormonal reproductive functions to parochial altruism

  2024cites this paper
• Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories

  2024cites this paper
• Lipid nanocapsules: A Novel Strategy for Brain Targeting via Nasal Administration

  2024cites this paper
• Left-right difference in brain pharmacokinetics following nasal administration via one-site nostrils.

  2024cites this paper
• Intranasal Nose-to-Brain Drug Delivery via the Olfactory Region in Mice: Two In-Depth Protocols for Region-Specific Intranasal Application of Antibodies and for Expression Analysis of Fc Receptors via In Situ Hybridization in the Nasal Mucosa.

  2024cites this paper
• In-vivo pharmacokinetic study of carmustine in rats after giving single-dose of carmustine API solution, flexible liposomes, in-situ nasal gel, optimized flexible liposomes embedded in-situ nasal gel, and marketed formulation.

  2024cites this paper
• Ribavirin in Modern Antitumor Therapy: Prospects for Intranasal Administration.

  2024cites this paper
• Intranasal Transfersomal Based In Situ Gel for Augmenting Methylphenidate Bioavailability and Brain Delivery: In Vitro and In Vivo Evaluation

  2024cites this paper
• The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases

  2024cites this paper
• Intranasal self-administration of high-pressure physiological saline isotonic solution ameliorates dry eye symptoms and tear film composition: a pilot study.

  2023cites this paper
• Evidence of Disturbed Insulin Signaling in Animal Models of Alzheimer's Disease.

  2023cites this paper
• Chances and challenges in intranasal administration delivery for brain disease treatment

  2023cites this paper
• ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery

  2023cites this paper
• Surface modified biodegradable nanoparticles of Gabapentin. An approach to increase cell uptake

  2023cites this paper
• Intranasal delivery of full-length anti-Nogo-A antibody: A potential alternative route for therapeutic antibodies to central nervous system targets

  2023cites this paper
• In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery

  2023cites this paper
• Development of a Nose-to-Brain system utilizing neural circuits based on a new concept

  2023cites this paper
• Intranasal GHK peptide enhances resilience to cognitive decline in aging mice

  2023cites this paper
• Enhancing Cytotoxicity of Tamoxifen Using Geranium Oil

  2022cites this paper
• Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System

  2022cites this paper
• Extracellular Vesicle-Mediated Delivery of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles to Mice Brain

  2022cites this paper
• Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Falling Short: The Contribution of Central Insulin Receptors to Gait Dysregulation in Brain Aging

  2022cites this paper
• Intranasal insulin and orexins to treat age-related cognitive decline.

  2021cites this paper
• Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer—Its Comparative Expression, Processing and Signaling in Mammalian CNS

  2021cites this paper
• New Insights into Nanoparticulate Carriers for Direct Nose‐to‐Brain Drug Delivery

  2021cites this paper
• Intranasal insulin

  2021cites this paper
• Nose to Brain Drug Delivery System

  2021cites this paper
• Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa

  2021cites this paper
• DEVELOPMENT OF RIVASTIGMINE LOADED SELF ASSEMBLED NANOSTRUCTURES OF NONIONIC SURFACTANTS FOR BRAIN DELIVERY

  2021cites this paper
• Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches

  2021cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma

  2021cites this paper
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021cites this paper
• Central insulin modulates dopamine signaling in the human striatum.

  2021cites this paper
• Assessment of Brain-To-Blood Drug Distribution Using Liquid Chromatography.

  2021cites this paper
• Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats

  2021cites this paper
• Intranasal Paclitaxel Alters Alzheimer’s Disease Phenotypic Features in 3xTg-AD Mice

  2021cites this paper
• Intranasal Insulin for Alzheimer’s Disease

  2021cites this paper
• Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19

  2021cites this paper
• Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

  2021cites this paper
• S-ketamine and intranasal application: alternatives for the castration of male suckling piglets?

  2021cites this paper
• Nasal Bioadhesive Drug Delivery Systems and Their Applications

  2020cites this paper
• Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation

  2020cites this paper
• Intranasal delivery of Thyroid hormones in MCT8 deficiency

  2020cites this paper
• Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis

  2020cites this paper
• TAT modification facilitates nose-to-brain transport of intact mPEG-PDLLA micelles: Evidence from aggregation-caused quenching probes

  2020cites this paper
• Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review

  2020cites this paper
• Les hautes dilutions homéopathiques vues par la physique : arguments en faveur d’une nanomédecine

  2020cites this paper
• Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of tacrine: In-vitro and in-vivo assessment

  2020cites this paper
• Distribution in the brain and possible neuroprotective effects of intranasally delivered multi-walled carbon nanotubes

  2020cites this paper
• Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats

  2020influential citation
• Role of Insulin in Neurotrauma and Neurodegeneration: A Review

  2020cites this paper
• Effect of cerebrospinal fluid circulation on nose-to-brain direct delivery and distribution of caffeine in rats.

  2020cites this paper
• Toward the therapeutic application of small interfering RNA bioconjugates in the central nervous system

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme

  2020cites this paper
• NDT_A_247677 1295..1307

  2020cites this paper
• Intranasal Insulin: a Treatment Strategy for Addiction

  2020cites this paper
• Improving the precision of intranasal oxytocin research

  2020cites this paper
• Cortical Organization of Centrifugal Afferents to the Olfactory Bulb: Mono- and Trans-synaptic Tracing with Recombinant Neurotropic Viral Tracers

  2019cites this paper
• Surface-Modified PLGA Nanoparticles for Targeted Drug Delivery to Neurons

  2019cites this paper
• Nanoparticle systems for nose-to-brain delivery

  2019cites this paper
• Executive Functioning, Visuo-Spatial and Inter-Personal Skill Preservation in Alzheimer’s and Mild Cognitive Impairment

  2019cites this paper
• Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye

  2019cites this paper
• Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration

  2019cites this paper
• P3-011: A DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT INVESTIGATION OF THE SAFETY OF INTRANASAL GLULISINE IN DOWN SYNDROME

  2019cites this paper
• A Review: Nose to Brain Drug Delivery for Various CNS Disorders

  2019cites this paper
• Intranasal Drug Delivery After Intracerebral Hemorrhage

  2019cites this paper
• Long-term intranasal insulin aspart: a profile of gene expression, memory, and insulin receptors in aged F344 rats.

  2019cites this paper
• Intranasal Treatment in Subarachnoid Hemorrhage

  2019cites this paper
• Paclitaxel Reduces Brain Injury from Repeated Head Trauma in Mice

  2019cites this paper
• Intranasal Delivering Method in the Treatment of Ischemic Stroke

  2019cites this paper
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Intracranial Inoculation Is More Potent Than Intranasal Inoculation for Inducing Optic Neuritis in the Mouse Hepatitis Virus-Induced Model of Multiple Sclerosis

  2018cites this paper
• Nasal Spray to the Rescue of Neurons in Stroke.

  2018cites this paper
• Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

  2018cites this paper